9 Analysts Have This To Say About Haemonetics
Latest Ratings for HAE Date Firm Action From To Feb 2022 Raymond James Maintains Outperform Jan 2022 Needham Downgrades Buy Hold Jan 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for HAE View the Latest Analyst Ratings read more